Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (7 ops.)
Latest filing published 15 Jun 2022 for HAEMONETICS CORP, €2,524. Read the official filing
Filing timeline
BuySaleDan Goldstein
Insider track record
Disclosed buys
0
Disclosed sells
7
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Dan Goldstein: trading record in brief
This profile gathers the share dealings of Dan Goldstein in Haemonetics Corp. In total, 9 filings cover trades dated from 17 May 2021 to 13 June 2022.
On the market, this insider has only sold: 7 sales, €35k in total. Other entries cover 2 share grants. So far in 2022, the count stands at no purchases and 4 sales.
The newest entry dates from 15 June 2022: an open-market sale of €2,524, in Haemonetics Corp. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. The legal deadline for a Form 4 is two business days after the transaction. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Dan Goldstein
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations9 total
42 shares@ US$62.600.0001% mcap7.3% of flowCommon StockSEC:0001127602-22-017544:0
249 shares@ US$62.690.0006% mcap41.8% of flowCommon StockSEC:0001127602-22-016885:0
134 shares@ US$59.100.0003% mcap21.6% of flowCommon StockSEC:0001127602-22-015364:0
50 shares@ US$56.100.0001% mcap7.7% of flowCommon StockSEC:0001127602-22-014976:0
39 shares@ US$59.875.5% of flowCommon StockSEC:0001127602-21-020056:0
81 shares@ US$55.0910.5% of flowCommon StockSEC:0001127602-21-019529:0
1,753 sharesCommon StockSEC:0001127602-21-018998:0
994 sharesCommon StockSEC:0001127602-21-017683:0
42 shares@ US$55.975.6% of flowCommon StockSEC:0001127602-21-017273:0
9 of 9 declarations
